551950-46-0 Usage
Uses
Used in Pharmaceutical Industry:
(4-METHOXY-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as an intermediate in the synthesis of pharmaceuticals for its role in creating various organic compounds that can be further developed into potential drug candidates.
Used in Agrochemical Industry:
(4-METHOXY-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as an intermediate in the synthesis of agrochemicals to develop compounds that can be used in the production of pesticides or other agricultural products.
Used in Organic Synthesis:
(4-METHOXY-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a reagent in organic synthesis for its ability to contribute to the formation of complex organic molecules.
Used in Chemical Research:
(4-METHOXY-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a research compound in chemical research to explore its properties and potential applications in various chemical reactions and processes.
Used in Medicinal Chemistry:
(4-METHOXY-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER may be used in medicinal chemistry for its potential role in the development of new drugs and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 551950-46-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,1,9,5 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 551950-46:
(8*5)+(7*5)+(6*1)+(5*9)+(4*5)+(3*0)+(2*4)+(1*6)=160
160 % 10 = 0
So 551950-46-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H16N2O3/c1-11(2,3)16-10(14)13-9-7-8(15-4)5-6-12-9/h5-7H,1-4H3,(H,12,13,14)
551950-46-0Relevant academic research and scientific papers
CARDIAC SARCOMERE INHIBITORS
-
Paragraph 0267, (2020/01/24)
Provided are compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2, Y1, Y2, L1, and G1 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
-
Paragraph 00349, (2014/01/09)
Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
